Clinical Trial Update: Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for Al18F-NOTA-FAPI PET/CT imaging in malignant tumors expressing fibroblast-activated protein, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignancy

Drugs mentioned

• Al18F-NOTA-FAPI PET/CT

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Malignancy | Phase 2, Phase 3 | Status: UNKNOWN